Cargando…
HER2 exon 27 mutations predict worse survival of breast cancer patients, especially in HER2‐negative patients
The aims of this study were to assess the prognostic value of the HER2 exon 27 mutations in breast cancer patients. Genomic DNA was isolated from peripheral blood leukocytes, and then HER2 exon 27 mutations were detected by direct sequencing. Survival curves were estimated by Kaplan–Meier curves and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727320/ https://www.ncbi.nlm.nih.gov/pubmed/29072371 http://dx.doi.org/10.1002/cam4.1236 |